Metofab Manufacturing Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 16 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -85.21%
- Profit Growth -105.55%
- Ebitda -579.89%
- Net Worth -5.42%
- Total Assets -1.70%
About Metofab Manufacturing
Metofab Manufacturing Private Limited (MMPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 September 2008 and has a history of 16 years and five months. Its registered office is in Aurangabad, Maharashtra, India.
The Company is engaged in the Automotive Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Smita Joshi and Hemant Joshi serve as directors at the Company.
Company Details
-
Location
Aurangabad, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U51504MH2008PTC186628
-
Company No.
186628
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 Sep 2008
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Metofab Manufacturing?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Smita Joshi
|
Director | 10-Sep-2008 | Current |
|
Hemant Joshi
|
Director | 10-Sep-2008 | Current |
Financial Performance of Metofab Manufacturing.
Metofab Manufacturing Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 85.21% decrease. The company also saw a substantial fall in profitability, with a 105.55% decrease in profit. The company's net worth dipped by a decrease of 5.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Metofab Manufacturing?
In 2019, Metofab Manufacturing had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Tejas Press Metal Works Private LimitedSmita Joshi and Hemant Joshi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Metofab Manufacturing?
Metofab Manufacturing has a workforce of 7 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Metofab Manufacturing, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Metofab Manufacturing's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.